By triggering withdrawal symptoms that mimic the original condition, these risky drugs keep patients hooked for years.
Do Proton Pump Inhibitors Work for Acid Reflux (GERD)?
Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.
Have you heard of GERD? Gastroesophageal reflux disease (GERD) is one of the most common disorders of the digestive tract, and has been on the rise in the United states. The usual symptoms include heartburn and the regurgitation of stomach contents back up toward the throat, which can leave a sour taste in the mouth. GERD causes millions of doctor visits and hospitalizations each year, and represents the highest annual cost of any digestive disease in the United States.
Chronic inflammation caused by acid reflux can lead to Barrett’s esophagus, a precancerous condition that involves changes in the esophageal lining that can turn into adenocarcinoma, the most common type of esophageal cancer in the United States. Even without the cancer risk, GERD itself can cause pain, bleeding, and narrowing of the esophagus from scar tissue that can interfere with swallowing. Nocturnal symptoms can be managed by eating dinner earlier, using a foam wedge to elevate your head in bed, and sleeping on your left side, but what can we do to prevent acid from creeping up in the first place?
There are PPIs, stomach acid–blocking “proton pump inhibitor” drugs with brand names like Prilosec, Prevacid, Nexium, Protonix, and AcipHex, but their use comes at a cost exceeding the tens of billions of dollars spent on them every year. In 2010, the U.S. Food and Drug Administration issued a safety alert implicating PPI use with fractures of the hip, wrist, and spine. By now, there have been two dozen such studies including more than two million people that, overall, show higher hip fracture rates among both short- and long-term users––at all dose levels.
The irony is that most people taking these drugs shouldn’t even be on them in the first place. The FDA approved the use of PPIs for ten days for the treatment of Helicobacter pylori (a kind of stomach infection), up to two weeks for heartburn, up to eight weeks for acid reflux disease, and for two to six months for ulcers. Yet, most patients in a community survey said they remained on the drugs for more than a year. And most report they were taking them for inappropriate reasons. PPIs are often wrongly prescribed for indigestion, for example. The risks of these drugs almost always exceed their benefits over the long run. Calls from regulatory authorities to stop this overuse have fallen on deaf doctor ears. Now that PPIs are available over the counter, the problem of overuse has almost certainly gotten worse.
And once you start taking them, it can be hard to stop. Between 44 and 59 percent of patients experience withdrawal symptoms that can last for weeks. When healthy, symptom-free volunteers were placed on these drugs for two months and then covertly switched to a placebo without their knowledge, many of them suddenly, out of nowhere, developed acid-related symptoms like heartburn or acid regurgitation. So the drugs caused the very disease that many people take them to treat. As one review asking “Are PPIs Addictive?” noted, when patients stop taking them and their symptoms come raging back, the cause may not be their acid reflux, but the drug itself. You can see why they’re such blockbuster moneymakers for drug companies, because they can keep you hooked by effectively making your symptoms worse any time you try to stop them.
In addition to higher rates of bone fractures, this class of drugs has been linked to increased risk of other long-term adverse effects, such as kidney damage, pneumonia, intestinal infections, colitis, cancer, and cardiovascular disease. (The effect of PPIs on blood vessels explains the recent case report “Abrupt-Onset, Profound Erectile Dysfunction in a Healthy Young Man After Initiating Over-The-Counter Omeprazole (Prilosec)”.) They also increase the risk of premature death. Wait, do proton pump inhibitors really increase mortality? A careful appraisal of the totality of available evidence suggests that, indeed, long-term use likely increases the risk of dying prematurely.
Perhaps the better strategy would be to just keep the acid in its place by minimizing the intake of foods and beverages that enable acid to escape. I’ll cover that, next.
Please consider volunteering to help out on the site.
- Hosseini M, Salari R, Akbari Rad M, Salehi M, Birjandi B, Salari M. Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation. J Evid Based Integr Med. 2018;23:2515690X18763294. doi:10.1177/2515690X18763294
- Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43(1):1-14. doi:10.1016/j.gtc.2013.11.006
- Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38(5):411-440. doi:10.1007/s12664-019-00979-y
- Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825-831. doi:10.1056/NEJM199903183401101
- Lu JH, Tsai CC, Lee JI, et al. Vegetarian Diet Reduced Gastroesophageal Reflux Disease in a Nationwide Longitudinal Survey in Taiwan. Nutrients. 2024;16(21):3712. Published 2024 Oct 30. doi:10.3390/nu16213712
- Schuitenmaker JM, Kuipers T, Smout AJPM, Fockens P, Bredenoord AJ. Systematic review: Clinical effectiveness of interventions for the treatment of nocturnal gastroesophageal reflux. Neurogastroenterol Motil. 2022;34(12):e14385. doi:10.1111/nmo.14385
- Salvo EM, Ferko NC, Cash SB, Gonzalez A, Kahrilas PJ. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther. 2021;54(2):129-143. doi:10.1111/apt.16407
- Ayoub J, White ND. GERD Management: The Case for Lifestyle in an Era of PPIs. Am J Lifestyle Med. 2017;11(1):24-28. Published 2017 Jan 10. doi:10.1177/1559827616671505
- Poly TN, Islam MM, Yang HC, Wu CC, Li YJ. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos Int. 2019;30(1):103-114. doi:10.1007/s00198-018-4788-y
- Safer DJ. Overprescribed Medications for US Adults: Four Major Examples. J Clin Med Res. 2019;11(9):617-622. doi:10.14740/jocmr3906
- Abrahami D, McDonald EG, Schnitzer M, Azoulay L. Trends in prescribing patterns of proton pump inhibitors surrounding new guidelines. Ann Epidemiol. 2021;55:24-26. doi:10.1016/j.annepidem.2020.12.002
- Sheikh I, Waghray A, Waghray N, Dong C, Wolfe MM. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2014;109(6):789-794. doi:10.1038/ajg.2013.421
- Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy
- Namikawa K, Björnsson ES. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?. Int J Mol Sci. 2024;25(10):5459. Published 2024 May 17. doi:10.3390/ijms25105459
- Moayyedi P, Lewis MA. Proton Pump Inhibitors and Dementia: Deciphering the Data. Am J Gastroenterol. 2017;112(12):1809-1811. doi:10.1038/ajg.2017.415
- Perry TW. Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating over-the-counter omeprazole: a case report. J Med Case Rep. 2021;15(1):360. Published 2021 Jul 24. doi:10.1186/s13256-021-02981-5
- Ben-Eltriki M, Green CJ, Maclure M, Musini V, Bassett KL, Wright JM. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence. Pharmacol Res Perspect. 2020;8(5):e00651. doi:10.1002/prp2.651
Motion graphics by Avo Media
Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.
Have you heard of GERD? Gastroesophageal reflux disease (GERD) is one of the most common disorders of the digestive tract, and has been on the rise in the United states. The usual symptoms include heartburn and the regurgitation of stomach contents back up toward the throat, which can leave a sour taste in the mouth. GERD causes millions of doctor visits and hospitalizations each year, and represents the highest annual cost of any digestive disease in the United States.
Chronic inflammation caused by acid reflux can lead to Barrett’s esophagus, a precancerous condition that involves changes in the esophageal lining that can turn into adenocarcinoma, the most common type of esophageal cancer in the United States. Even without the cancer risk, GERD itself can cause pain, bleeding, and narrowing of the esophagus from scar tissue that can interfere with swallowing. Nocturnal symptoms can be managed by eating dinner earlier, using a foam wedge to elevate your head in bed, and sleeping on your left side, but what can we do to prevent acid from creeping up in the first place?
There are PPIs, stomach acid–blocking “proton pump inhibitor” drugs with brand names like Prilosec, Prevacid, Nexium, Protonix, and AcipHex, but their use comes at a cost exceeding the tens of billions of dollars spent on them every year. In 2010, the U.S. Food and Drug Administration issued a safety alert implicating PPI use with fractures of the hip, wrist, and spine. By now, there have been two dozen such studies including more than two million people that, overall, show higher hip fracture rates among both short- and long-term users––at all dose levels.
The irony is that most people taking these drugs shouldn’t even be on them in the first place. The FDA approved the use of PPIs for ten days for the treatment of Helicobacter pylori (a kind of stomach infection), up to two weeks for heartburn, up to eight weeks for acid reflux disease, and for two to six months for ulcers. Yet, most patients in a community survey said they remained on the drugs for more than a year. And most report they were taking them for inappropriate reasons. PPIs are often wrongly prescribed for indigestion, for example. The risks of these drugs almost always exceed their benefits over the long run. Calls from regulatory authorities to stop this overuse have fallen on deaf doctor ears. Now that PPIs are available over the counter, the problem of overuse has almost certainly gotten worse.
And once you start taking them, it can be hard to stop. Between 44 and 59 percent of patients experience withdrawal symptoms that can last for weeks. When healthy, symptom-free volunteers were placed on these drugs for two months and then covertly switched to a placebo without their knowledge, many of them suddenly, out of nowhere, developed acid-related symptoms like heartburn or acid regurgitation. So the drugs caused the very disease that many people take them to treat. As one review asking “Are PPIs Addictive?” noted, when patients stop taking them and their symptoms come raging back, the cause may not be their acid reflux, but the drug itself. You can see why they’re such blockbuster moneymakers for drug companies, because they can keep you hooked by effectively making your symptoms worse any time you try to stop them.
In addition to higher rates of bone fractures, this class of drugs has been linked to increased risk of other long-term adverse effects, such as kidney damage, pneumonia, intestinal infections, colitis, cancer, and cardiovascular disease. (The effect of PPIs on blood vessels explains the recent case report “Abrupt-Onset, Profound Erectile Dysfunction in a Healthy Young Man After Initiating Over-The-Counter Omeprazole (Prilosec)”.) They also increase the risk of premature death. Wait, do proton pump inhibitors really increase mortality? A careful appraisal of the totality of available evidence suggests that, indeed, long-term use likely increases the risk of dying prematurely.
Perhaps the better strategy would be to just keep the acid in its place by minimizing the intake of foods and beverages that enable acid to escape. I’ll cover that, next.
Please consider volunteering to help out on the site.
- Hosseini M, Salari R, Akbari Rad M, Salehi M, Birjandi B, Salari M. Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation. J Evid Based Integr Med. 2018;23:2515690X18763294. doi:10.1177/2515690X18763294
- Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43(1):1-14. doi:10.1016/j.gtc.2013.11.006
- Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38(5):411-440. doi:10.1007/s12664-019-00979-y
- Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825-831. doi:10.1056/NEJM199903183401101
- Lu JH, Tsai CC, Lee JI, et al. Vegetarian Diet Reduced Gastroesophageal Reflux Disease in a Nationwide Longitudinal Survey in Taiwan. Nutrients. 2024;16(21):3712. Published 2024 Oct 30. doi:10.3390/nu16213712
- Schuitenmaker JM, Kuipers T, Smout AJPM, Fockens P, Bredenoord AJ. Systematic review: Clinical effectiveness of interventions for the treatment of nocturnal gastroesophageal reflux. Neurogastroenterol Motil. 2022;34(12):e14385. doi:10.1111/nmo.14385
- Salvo EM, Ferko NC, Cash SB, Gonzalez A, Kahrilas PJ. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther. 2021;54(2):129-143. doi:10.1111/apt.16407
- Ayoub J, White ND. GERD Management: The Case for Lifestyle in an Era of PPIs. Am J Lifestyle Med. 2017;11(1):24-28. Published 2017 Jan 10. doi:10.1177/1559827616671505
- Poly TN, Islam MM, Yang HC, Wu CC, Li YJ. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos Int. 2019;30(1):103-114. doi:10.1007/s00198-018-4788-y
- Safer DJ. Overprescribed Medications for US Adults: Four Major Examples. J Clin Med Res. 2019;11(9):617-622. doi:10.14740/jocmr3906
- Abrahami D, McDonald EG, Schnitzer M, Azoulay L. Trends in prescribing patterns of proton pump inhibitors surrounding new guidelines. Ann Epidemiol. 2021;55:24-26. doi:10.1016/j.annepidem.2020.12.002
- Sheikh I, Waghray A, Waghray N, Dong C, Wolfe MM. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2014;109(6):789-794. doi:10.1038/ajg.2013.421
- Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy
- Namikawa K, Björnsson ES. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?. Int J Mol Sci. 2024;25(10):5459. Published 2024 May 17. doi:10.3390/ijms25105459
- Moayyedi P, Lewis MA. Proton Pump Inhibitors and Dementia: Deciphering the Data. Am J Gastroenterol. 2017;112(12):1809-1811. doi:10.1038/ajg.2017.415
- Perry TW. Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating over-the-counter omeprazole: a case report. J Med Case Rep. 2021;15(1):360. Published 2021 Jul 24. doi:10.1186/s13256-021-02981-5
- Ben-Eltriki M, Green CJ, Maclure M, Musini V, Bassett KL, Wright JM. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence. Pharmacol Res Perspect. 2020;8(5):e00651. doi:10.1002/prp2.651
Motion graphics by Avo Media
Republishing "Do Proton Pump Inhibitors Work for Acid Reflux (GERD)?"
You may republish this material online or in print under our Creative Commons licence. You must attribute the article to NutritionFacts.org with a link back to our website in your republication.
If any changes are made to the original text or video, you must indicate, reasonably, what has changed about the article or video.
You may not use our material for commercial purposes.
You may not apply legal terms or technological measures that restrict others from doing anything permitted here.
If you have any questions, please Contact Us
Do Proton Pump Inhibitors Work for Acid Reflux (GERD)?
LicenseCreative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Content URLDoctor's Note
Isn’t that wild about the withdrawal? The fact that the pills can actually cause the very symptoms you’re trying to fix? How diabolical for Big Pharma to try to keep you hooked on drugs that shouldn’t even be taken long-term.
This is the first in a three-video series. Stay tuned for The Best Diet for Treating Acid Reflux (GERD) and The Health Benefits of Psyllium, Flaxseeds, and Other High-Fiber Foods.
For even more on pain management, check out my new book How Not to Hurt, available now for preorders. (All proceeds received from book sales are donated directly to charity.)
If you haven't yet, you can subscribe to our free newsletter. With your subscription, you'll also get notifications for just-released blogs and videos. Check out our information page about our translated resources.